Skip to main content
Publication date
2017 Jun
Authors
Smolen, JS Landewe, R Bijlsma, J Burmester, G Chatzidionysiou, K Dougados, M Nam, J Ramiro, S Voshaar, M van Vollenhoven, R Aletaha, D Aringer, M Boers, M Buckley, CD Buttgereit, F Bykerk, V Cardiel, M Combe, B Cutolo, M van Eijk-Hustings, Y Emery, P Finckh, A Gabay, C Gomez-Reino, J Gossec, L Gottenberg, JE Hazes, JMW Huizinga, T Jani, M Karateev, D Kouloumas, M Kvien, T Li, ZG Mariette, X McInnes, I Mysler, E Nash, P Pavelka, K Poor, G Richez, C van Riel, P Rubbert-Roth, A Saag, K da Silva, J Stamm, T Takeuchi, T Westhovens, R de Wit, M van der Heijde, D
Author KI Usernames
Chatzidionysiou, K|aikcha van Vollenhoven, R|ronvan
Pubmed ID
28264816
Journal
Annals of the rheumatic diseases
Doctype
Review
KI Connection
Låg
Mesh SV
Antireumatiska medel Glukokortikoider Januskinaser Kombinationsbehandling Ledgångsreumatism Läkemedelsutbyte Metotrexat Monoklonala antikroppar Människa Patientinflytande Proteinkinashämmare Tidsfaktorer Tumörnekrosfaktor-alfa
Mesh EN
Antibodies, Monoclonal Antirheumatic Agents Arthritis, Rheumatoid Drug Substitution Drug Therapy, Combination Glucocorticoids Janus Kinases Methotrexate Patient Participation Protein Kinase Inhibitors Time Factors Tumor Necrosis Factor-alpha
First date
2017-06-04T10:15:25.595Z